Thermo Fisher Scientific Inc.
TMO
$459.30
$6.701.48%
NYSE
| 03/28/2026 | 12/31/2025 | 09/27/2025 | 06/28/2025 | 03/29/2025 | |
|---|---|---|---|---|---|
| Net Income | -15.94% | 21.53% | -0.06% | 7.30% | -17.65% |
| Total Depreciation and Amortization | 0.82% | 8.49% | -0.74% | -4.11% | -4.99% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -125.47% | 467.86% | 133.33% | -162.50% | -151.61% |
| Change in Net Operating Assets | -348.77% | 529.81% | 85.67% | 49.05% | -339.90% |
| Cash from Operations | -65.52% | 54.40% | 60.04% | 93.50% | -78.02% |
| Capital Expenditure | 19.14% | -15.10% | -37.41% | 18.78% | 24.58% |
| Sale of Property, Plant, and Equipment | -66.67% | 575.00% | 300.00% | -91.67% | -29.41% |
| Cash Acquisitions | -- | 100.00% | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -79.08% | 323.25% | 6,180.00% | 102.82% | -136.65% |
| Cash from Investing | -1,105.72% | 121.61% | -1,331.60% | 45.35% | -2,735.00% |
| Total Debt Issued | 14.39% | 349.22% | -- | -100.00% | -- |
| Total Debt Repaid | -9.88% | -115.24% | 24.14% | 6.09% | 66.48% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -8,008.11% | 96.16% | -- | 100.00% | -100.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 0.00% | 0.61% | -0.62% | -8.72% | 0.00% |
| Other Financing Activities | -56.04% | 2,375.00% | 90.48% | -193.33% | 364.71% |
| Cash from Financing | -69.00% | 657.91% | 36.23% | -871.57% | 97.22% |
| Foreign Exchange rate Adjustments | 1,400.00% | 92.00% | -124.12% | 740.54% | 113.55% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -100.00% | 200.00% |
| Net Change in Cash | -183.87% | 403.55% | -701.39% | 226.52% | 120.95% |